330 related articles for article (PubMed ID: 23800495)
1. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Sakai H; Kiyohara Y; Minematsu K; Hayashi K; Kitazono T
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
[TBL] [Abstract][Full Text] [Related]
2. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
Tsukamoto Y; Takizawa S; Takahashi W; Mase H; Miyachi H; Miyata T; Takagi S
J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
Tanahashi N; Yamaguchi T; Awano H; Matsuda H
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
[TBL] [Abstract][Full Text] [Related]
4. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
Wada T; Yasunaga H; Inokuchi R; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
J Neurol Sci; 2014 Oct; 345(1-2):106-11. PubMed ID: 25085762
[TBL] [Abstract][Full Text] [Related]
5. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Shinohara Y; Saito I; Kobayashi S; Uchiyama S
Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
[TBL] [Abstract][Full Text] [Related]
6. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
[TBL] [Abstract][Full Text] [Related]
7. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
Yamaguchi T; Awano H; Matsuda H; Tanahashi N;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
[TBL] [Abstract][Full Text] [Related]
9. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
[TBL] [Abstract][Full Text] [Related]
10. Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study.
Naritomi H; Moriwaki H; Metoki N; Nishimura H; Higashi Y; Yamamoto Y; Yuasa H; Oe H; Tanaka K; Saito K; Terayama Y; Oda T; Tanahashi N; Kondo H;
Drugs R D; 2010; 10(3):155-63. PubMed ID: 20945946
[TBL] [Abstract][Full Text] [Related]
11. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
Baba H; Sugimori H; Nanishi E; Nagata H; Lee S; Kuwashiro T; Hashizume M
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):903.e5-8. PubMed ID: 21421331
[TBL] [Abstract][Full Text] [Related]
12. Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry.
Kuwashiro T; Sugimori H; Kamouchi M; Ago T; Kitazono T; Iida M
J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):561-8. PubMed ID: 21376631
[TBL] [Abstract][Full Text] [Related]
13. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
Toyoda K; Fujii K; Kamouchi M; Nakane H; Arihiro S; Okada Y; Ibayashi S; Iida M
J Neurol Sci; 2004 Jun; 221(1-2):11-7. PubMed ID: 15178207
[TBL] [Abstract][Full Text] [Related]
14. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Kikuchi K; Tancharoen S; Matsuda F; Biswas KK; Ito T; Morimoto Y; Oyama Y; Takenouchi K; Miura N; Arimura N; Nawa Y; Meng X; Shrestha B; Arimura S; Iwata M; Mera K; Sameshima H; Ohno Y; Maenosono R; Tajima Y; Uchikado H; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I; Kawahara K
Biochem Biophys Res Commun; 2009 Dec; 390(4):1121-5. PubMed ID: 19737535
[TBL] [Abstract][Full Text] [Related]
15. Clinical Effects of Early Edaravone Use in Acute Ischemic Stroke Patients Treated by Endovascular Reperfusion Therapy.
Enomoto M; Endo A; Yatsushige H; Fushimi K; Otomo Y
Stroke; 2019 Mar; 50(3):652-658. PubMed ID: 30741623
[TBL] [Abstract][Full Text] [Related]
16. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
17. Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy.
Unno Y; Katayama M; Shimizu H
Clin Drug Investig; 2010; 30(3):143-55. PubMed ID: 20155987
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
Kumagai N; Origasa H; Nagao T; Takekawa H; Okuhara Y; Yamaguchi T
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):792-8. PubMed ID: 22633681
[TBL] [Abstract][Full Text] [Related]
20. Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry.
Ishikawa H; Wakisaka Y; Matsuo R; Makihara N; Hata J; Kuroda J; Ago T; Kitayama J; Nakane H; Kamouchi M; Kitazono T;
Cerebrovasc Dis; 2016; 42(5-6):395-403. PubMed ID: 27376661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
